Cargando…
Tuberculous and Non-Tuberculous Granulomatous Lymphadenitis in Patients Receiving Imatinib Mesylate (Glivec) for Metastatic Gastrointestinal Stromal Tumor
BACKGROUND: Imatinib mesylate (IM) is the standard treatment for BCR-ABL-positive chronic myelogenous leukemia (CML) and is the first-line adjuvant and palliative treatment for metastatic and inoperable gastrointestinal stromal tumor (GIST). IM is not known to be associated with an increased risk fo...
Autores principales: | Agaimy, Abbas, Brueckl, Valeska, Schmidt, Daniela, Krieg, Stephanie, Ullrich, Evelyn, Meidenbauer, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618090/ https://www.ncbi.nlm.nih.gov/pubmed/23569448 http://dx.doi.org/10.1159/000348712 |
Ejemplares similares
-
Gastrointestinal Stromal Tumor: A Rare Abdominal Tumor
por: Shaheen, Shagufta, et al.
Publicado: (2013) -
Synchronous Sporadic Gastrointestinal Stromal Tumors in the Stomach and Jejunum: Report of a Case
por: Nakayama, Yoshifumi, et al.
Publicado: (2013) -
Metachronous Gastrointestinal Stromal Tumor and Acute Leukemia after Liver Transplantation for Cholangiocellular Carcinoma: Is There a Link?
por: Mrzljak, Anna, et al.
Publicado: (2013) -
Human Tuberculous Meningitis Caused by Mycobacterium caprae
por: Hansen, Niels, et al.
Publicado: (2012) -
A Case of Tuberculous Granulomatous Panniculitis without Vasculitis
por: Tehrany, Yassaman Alipour, et al.
Publicado: (2015)